Rahul Kakkar serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rahul Kakkar has executed 4 insider transactions totaling $252.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 702,515 shares valued at $42.2M.
Rahul Kakkar currently holds 702,515 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rahul Kakkar has been a net buyer of PAND stock. They have purchased $252.0K and sold $0 worth of shares.
Rahul Kakkar's most recent insider trade was on Apr 1, 2021, when they sold 702,515 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $60.00 |
| Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 21,133 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $252.0K | Purchase | 14,000 | $18.00 | Discretionary |